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Inhibition of nitric oxide and prostaglandin E2 production by pyrrolylated-chalcones: 
synthesis, biological activity, crystal structure analysis, and molecular docking studies 
 
ABSTRACT 
In search of potent anti-inflammatory agents, twenty-four chalcone derivatives including seven 
new compounds (13 – 17, 21 and 23) containing pyrrole moiety were designed, synthesized, 
and assessed for their nitric oxide (NO) and prostaglandin E2 (PGE2) suppression ability on 
IFN-γ/LPS-induced RAW 264.7 macrophage cells. Results showed that none of the 
synthesized compounds were PAINS-associated molecules, with 3-(2,5-dimethoxyphenyl)-1-
(1H-pyrrol-2-yl)-prop-2-en-1-one (compound 16) exhibiting remarkable inhibition activity 
towards PGE2 and NO production with IC50 values of 0.5 ± 1.5 µM and 12.1 ± 1.5 µM, 
respectively. Physicochemical and ADMET studies showed that majority of the compounds 
obey to Lipinski's rule of five (RO5) having high blood brain barrier (BBB) penetration, human 
intestinal absorption (HIA), P- glycoprotein (PgP) inhibition and plasma binding protein (PPB) 
inhibition. The obtained atomic coordinates for the single-crystal XRD of 16 were then applied 
in a molecular docking simulation, and compound 16 was found to participate in a number of 
important binding interactions in the binding sites of ERK and mPGES-1. Based on these 
results, we have observed the potential of compound 16 as a new hit anti-inflammatory agent, 
and these findings could serve as a basis for further studies on its mechanism of action. 
